Nutrient-driven O-GlcNAcylation is strikingly abundant in the brain and has been linked to development and neurodegenerative disease. We selectively targeted the O-GlcNAcase (Oga) gene in the mouse brain to define the role of O-GlcNAc cycling in the central nervous system. Brain knockout animals exhibited dramatically increased brain O-GlcNAc levels and pleiotropic phenotypes, including early-onset obesity, growth defects, and metabolic dysregulation. Anatomical defects in the Oga knockout included delayed brain differentiation and neurogenesis as well as abnormal proliferation accompanying a developmental delay. The molecular basis for these defects included transcriptional changes accompanying differentiating embryonic stem cells. In Oga KO mouse ES cells, we observed pronounced changes in expression of pluripotency markers, including Sox2, Nanog, and Otx2. These findings link the O-GlcNAc modification to mammalian neurogenesis and highlight the role of this nutrient-sensing pathway in developmental plasticity and metabolic homeostasis. serves as a model for the role of O-GlcNAcylation in development and the maintenance of metabolic homeostasis. Brain O-GlcNAcylation, development, and metabolism APRIL 14, 2017 • VOLUME 292 • NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 6077 Figure 5. Oga KO mouse embryonic stem cells demonstrate unique pluripotency and a neurogenesis expression pattern. A, levels of O-GlcNAc proteins and enzymes (OGT and OGA) in WT and Oga KO mESCs analyzed by Western blotting (WB). B, mRNA levels of Oga in WT and Oga KO mESCs analyzed by qPCR. C, qPCR analysis of WT and Oga KO mESC mRNA level of pluripotency and differentiation markers. ns, APRIL 14, 2017 • VOLUME 292 • NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 6081
Among the most nutrient-dependent organs (1, 2) , the brain is constitutively lacking in fuel storage and uses circulating nutrients to develop and function. As a result, the brain uses 120 g of glucose daily. At rest, that accounts for 60% of the whole body utilization of glucose. Consequently, nutrient availability impacts not only brain fetal development but can also have long-term developmental consequences (1, (3) (4) (5) (6) . Because the interplay between glucose metabolism and the brain is emerging as a critical area for further research (7) , this study was designed to decipher the links between normal brain physiology and the highly glucose-dependent post-translational modification O-GlcNAcylation. O-GlcNAcylation is the addition of a single sugar (N-acetylglucosamine) onto serine or threonine residues of intracellular proteins (8, 9) . Two enzymes regulate O-GlcNAc cycling: O-GlcNAc transferase (OGT) 2 and O-GlcNAcase (OGA). OGT adds and OGA removes the Ser/ Thr-linked GlcNAc residues in a highly dynamic fashion. Already described on over 1000 proteins, O-GlcNAcylation has emerged as a dynamic modulator of signaling pathways, much like phosphorylation (8, 9) . The substrate for the O-GlcNAc modification (UDP-GlcNAc) is dependent on glucose metabolism but also influenced by cellular amino acid, fatty acid, and nucleotide supplies (10 -14) . Therefore, O-GlcNAcylation is considered a nutrient sensor, fluctuating with nutrient intake and influencing signaling pathways in response to nutritional status. O-GlcNAc metabolism is essential for mammalian development. In mice, OGT is required for stem cell viability, and conditional KO is lethal at embryonic day 4.5 (15) . Stem cell homeostasis defects are thought to be responsible for this lethality, and multiple pluripotency factors, such as SOX2 and OCT4, have been demonstrated to be critically O-GlcNAcregulated (16) . We demonstrated previously that Oga KO leads to a high incidence of neonatal lethality and severe developmental defects (17) and has also been linked to a delayed differentiation of all three embryonic layers (18) . In addition to being highly affected by glucose levels (3, 5, 7) , the brain is also the organ with the highest O-GlcNAcylation level (19) , and key neuronal proteins are O-GlcNAcylated (20) . Neuron-specific Ogt KO in mice resulted in severe defects and early postnatal death (21) . O-GlcNAcylation has been linked previously to brain organization (22) , axonal and dendritic growth and function (23, 24) , neuronal metabolic regulation (25) , and neurodegenerative diseases (26 -28) . Nevertheless, the majority of these studies focused on modulating OGT activity and decreasing the O-GlcNAc level. In this study, we generated a mouse model of hyper-O-GlcNAcylated brain (Oga knockout, Oga ⌬Br ). In these mice, OGT correctly modifies proteins, whereas OGA is no longer present to remove it. Oga ⌬Br mice exhibited clear phenotypes of incomplete penetrance, including a short stature/ face, microcephaly, high body fat percentage, and hypotonia as well as metabolic and growth deficits associated with hypopituitarism (significant anatomical loss of the anterior pituitary). In addition, all four of the ventricles of the brain were enlarged, suggesting extensive changes in ongoing neurogenesis in the periventricular zones. Moreover, direct measures of neurogenesis confirmed a substantial developmental delay and changes in proliferation and migration. In addition, in vitro differentiation of WT or Oga KO mESCs into the neuronal lineage demonstrated differential expression of several critical regulators in Oga KO stem cells, including the homeobox protein Sox2, Nanog, Sox1, and Otx2. This genetically generated alteration in O-GlcNAcylation
Results

Brain-specific knockout of Oga (Oga ⌬Br ) results in anatomical and behavioral phenotypes
We have previously produced a floxed allele of the Oga (MGEA5) locus in mice. In these mice, Cre recombinase generates a deletion removing about 500 bp of the promoter region and the first exon of Oga, resulting in the production of undetectable levels of Oga messenger RNA (17) . As we reported previously, loss of Oga in early development resulted in perinatal lethality of the majority of the animals. Surviving Oga knockout pups showed numerous metabolic and anatomical phenotypes, including changes in brain structure (17) . To better understand the phenotype in the CNS, we generated a brainspecific Oga KO by crossing Oga flox/Ϫ mice with a mouse line expressing a highly brain-specific Nes-Cre transgene. In animals harboring the homozygous Oga-null allele Oga ⌬Br , loss of O-GlcNAcase greatly increased O-GlcNAcylation in the brain, whereas no increase was shown in the liver or other tissues ( Fig. 1A and supplemental Fig. S1, A and B) . The loss of brain O-GlcNAcase was nearly complete and associated with modest changes in OGT isoforms in the brain. Moreover, immunofluorescence staining of O-GlcNAcylated proteins in many brain regions was significantly increased in Oga ⌬Br versus WT mice in the region around the dentate gyrus ( Fig. 1B ). Brain coronal sections revealed an enlargement of both lateral third and fourth ventricles (Fig. 1C ). Furthermore, inspection of the intact brain revealed that the cortical brain and olfactory bulb were also significantly reduced in size ( Fig. 1D ). This effect was most dramatic in the olfactory bulb, which resulted in a 50% reduction in the size of the olfactory bulb relative to the cortex compared with WT animals (Fig. 1E ). It is interesting to note that, in most mammals, the olfactory bulb and the dentate gyrus in the hippocampus are the major sites of adult neurogenesis (29) . Despite these anatomical changes, Oga ⌬Br mice were generally healthy, and female animals were fertile. The majority (90%) exhibited a normal lifespan that did not differ significantly from their littermates. However, Oga ⌬Br animals were smaller and could be distinguished from their littermates because of their shorter face ( Fig. 1 , F and G). Despite the unchanged O-GlcNAc cycling in the liver, we noticed upon dissection that Oga ⌬Br animals developed a fatty liver phenotype (supplemental Fig. S1C ), which was consistent with an overall increase in fat mass in the knockout animals. We also assessed behavioral changes and noticed that Oga ⌬Br animals exhibited hypotonia and a strong paw-clasping phenotype ( Fig.  1H and supplemental Movie S1, A and B), which was quantified according to the hind limb reflex score from 0 -2 ( Fig. 1I ). The Oga ⌬Br animals also exhibited an agitation phenotype not seen in control or floxed littermates (supplemental Movie S1, C and D).
Oga ⌬Br leads to delayed development of the isocortex and anterior pituitary
Knowing that the Nestin expression driving the Oga KO occurs in early embryonic development (ectoderm), we investigated Oga ⌬Br embryogenesis at 17.5 days post-coitus (dpc). The head as well as the pituitary gland of the Oga ⌬Br embryo appeared smaller, and this persisted in young adult animals ( Fig. 2 , A-E, quantified in H). Moreover, forebrain ( Fig. 2B , Cortical neuroepithelium), midbrain ( Fig. 2C , Superior colliculus), and hind brain ( Fig. 2D , Metencephalon) development was delayed by ϳ2 days according to reference slides at 15.5 dpc. Finally, the lateral third and fourth ventricles were also enlarged in Oga ⌬Br 17.5-dpc embryos (Fig. 2 , B and C). Other regions of the brain, like the cerebellum, were unaffected (supplemental Fig. S2 ). In embryonic and adult Oga ⌬Br animals, we noted that the pituitary gland was also significantly reduced in size compared with WT littermates (Fig. 2 , E and F, quantified in H and I). Upon dissection, we noted that this was due to a selective reduction of the anterior pituitary, particularly the pars distalis ( Fig. 2F ). Strikingly, the percentage of acidophils (somatotrophs and mammotrophs) relative to basophils (corticotrophs, thyrotrophs, and gonadotrophs) was decreased by 5-fold in Oga ⌬Br animals ( Fig. 2 , G, quantified in J).
Oga ⌬Br mice exhibit early-onset obesity, growth defects, and metabolic dysregulation
The dramatically reduced size of the anterior pituitary in Oga ⌬Br animals and the reduction in acidophilic somatotrophs were striking and anticipated to be associated with substantial metabolic deregulation. As noted in Fig. 1F , the animals were significantly shorter and obese even as young animals. As shown in Fig. 3 , numerous metabolic parameters were altered in the homozygous Oga ⌬Br animals compared with their WT littermates. The animals showed a greatly elevated body fat percentage (40%) even at a young age (Fig. 3A) . The animals maintained their higher body fat content throughout adulthood. However, neither the body weight ( Fig. 3B ) nor the food intake ( Fig. 3C ) of the Oga ⌬Br mice differed significantly from the wildtype animals. Circulating FFAs ( Fig. 3D and supplemental Table S1 ) were significantly lower and triglycerides ( Fig. 3E and supplemental Table S1 ) significantly higher in Oga ⌬Br animals compared with their WT littermates. Consistent with elevated lipid stores, the levels of both leptin ( Fig. 3F and supplemental Table S1 ) and adiponectin ( Fig. 3G and supplemental Table S1 ) were elevated significantly in Oga ⌬Br animals. Moreover, the Oga ⌬Br animals also developed a fatty liver phenotype (supplemental Fig. S1C ). Nevertheless, in non-stimulated adult Oga ⌬Br animals, the levels of growth hormone, corticosterone, T3, and T4 hormones remained unchanged, suggesting a potential developmental effect leading to metabolic imbalance (supplemental Figs. S3, C, and S4. Although both fasting and non-fasting blood glucose levels remained in the normal range (supplemental Fig. S3, A and B) , both males and females showed a highly significant elevation in the level of insulin (ϳ6-fold) ( Fig. 3H and supplemental Table S1 ) and a concomitant decrease in the circulating level of IGF-1 ( Fig. 3I and supplemental Table S1 ). Thus, disruption of Oga ⌬Br metabolic homeostasis was not associated with changes in satiety but linked to significantly decreased levels of FFA and IGF-1 and increased levels of circulating leptin, triglycerides, insulin, and adiponectin.
The balance between proliferation and neuronal differentiation is impaired in Oga KO mice and cells
The anatomical changes in the brain of Oga KO animals suggested that neurogenesis might be altered. The balance between proliferation and differentiation is a critical aspect of neuronal development. Thus, we investigated the proliferative state of the embryonic brain at 17.5 dpc. Staining with BrdU of the embryonic brain revealed a much higher proliferation rate in Oga ⌬Br versus the WT (Fig. 4A ). The subventricular zone, responsible for neurogenesis of the cortex (Fig. 4B ), exhibited elevated BrdU staining, as did the olfactory epithelium ( Fig. 4C ) and the developing pituitary gland (Fig. 4D ). These findings suggest that neurogenesis was prolonged in the knockout animals. However, examination of the adult subventricular zone region in Oga ⌬Br did not exhibit persistent differences in the proliferation markers proliferating cell nuclear antigen (PCNA) or doublecortin (DCX) (Fig. 4E ). Nevertheless, DCX staining of the adult olfactory bulb itself revealed an elevated number of neuronal precursors or immature neurons in Oga ⌬Br (Fig. 4F ). Interestingly, in Oga ⌬Br mice, the cortex layering was altered and compressed ( Fig. 4G) . Moreover, the fifth cortical layer was extensively depleted in pyramidal neurons in comparison with the WT (Fig. 4G, #5 ). The pyramidal neurons of the hippocampus in adult Oga ⌬Br mice (Fig. 4 , H and I) also exhibited fewer dendritic extensions than those in WT animals ( Fig. 4 , H, #1 and #2, and I). Although neurogenesis was demonstrably altered, staining of glial fibrillary acidic protein in the Oga ⌬Br brain did not exhibit significant differences, suggesting that the glial cell population is largely unaffected (supplemental Fig. S5 ). Furthermore, we demonstrated that the altered structure and size of the Oga ⌬Br brain were not due to increased apoptosis or neurodegeneration by using TUNEL (supplemental Fig. S6 ) and disintegrative degeneration stain (de Olmos amino cupric silver) (supplemental Fig. S7 ), respectively. Intriguingly, Oga ⌬Br animals exhibited slightly less neurodegenerative damage than WT animals, consistent with a protective effect of loss of O-GlcNAcase. This is consistent with reports suggesting that O-GlcNAcase inhibitors may be neuroprotective (30) . It is interesting to note that, in the adult, neurogenesis persists in two main sites in the brain, the olfactory epithelium and the dentate gyrus. This process is highly dependent upon environmental cues, and altered neurogenesis is observed in neurodegenerative diseases such as Alzheimer's, Huntington's, and Parkinson's disease (31) .
Oga KO mESCs exhibit altered pluripotency and differentiation factor expression as well as neuronal differentiation
O-GlcNAc cycling has been suggested to play an important role in regulating stem cell differentiation by acting on core components of the pluripotency network (16, 32) . To decipher the factors involved in the Oga ⌬Br phenotype, we probed the mRNA expression of critical pluripotency and differentiation markers in mESCs derived from Oga KO animals and WT littermates. mESCs were derived in vitro from 3.5-dpc embryos of Brain O-GlcNAcylation, development, and metabolism APRIL 14, 2017 • VOLUME 292 • NUMBER 15
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Oga KO mice and wild-type animals (17) . As expected, OGA protein and mRNA levels were absent in Oga KO mESCs, resulting in high levels of O-GlcNAcylated proteins compared with the WT (Fig. 5, A and B) . To observe the first step in neural differentiation, 2i were removed from the cell culture medium to prime the mESCs and induce the expression of Nestin (Fig.  5C ). Following induction, expression of a panel of pluripotency (Fig. 5C, left) and differentiation (Fig. 5C, right) factors were assessed by qPCR. In Oga KO mESCs, Oct4 transcript levels were not significantly altered (Fig. 5C ). In contrast, levels of the pluripotency factor Sox2 were elevated, whereas levels of Nanog were down-regulated. Most interestingly, the priming/ predifferentiation factors Sox1, Nestin, and Otx2 were more highly expressed in Oga KO mESCs than in the wild type ( Fig.  5C ), suggesting a premature switch to primed pluripotency. Some of the established neuronal markers were also more highly expressed in Oga KO mESCs, including Mag, Aldh1, and Gfap (Fig. 5C ). To directly examine the differentiation process, long-term cultures differentiated for 13 days with retinoic acid revealed that Oga KO stem cells showed a dramatically diminished ability to differentiate into neuronal lineages, as evidenced by the expression of neuronal markers such as ␤3-tubulin ( Fig. 6, A-D) . The quantitative changes observed during differentiation are shown in Fig. 6E .
Discussion
The developing mammalian brain increases in size 6-fold from the third trimester to the end of the first year (3) and has been estimated to consume around 60% of the whole body glucose in a resting phase (33) . As a result, the nutrient supply to the brain impacts not only fetal development but can also have long-term consequences (1, (3) (4) (5) (6) . Interestingly, diet has been associated with a number of pre-or post-natal brain developmental delays (1, 4) , obesity (34 -36) , and diabetes (37) . Because the interplay between maternal glucose metabolism and the developing brain is emerging as a critical area for further research (7) , this study is designed to clarify the role of ongoing O-GlcNAc cycling, a nutrient-sensing post-translational modification in brain development and physiology. We have created a brain-specific Oga KO, which increases the level of O-GlcNAc and may mimic what can happen in an animal chronically exposed to a high-carbohydrate diet. In these mice, OGT correctly modifies proteins, whereas OGA is no longer present to remove it, leading to hyper-O-GlcNAcylation on diverse protein targets in the brain. After confirming the selective deletion and subsequent increase of O-GlcNAcylation in the brain, we investigated the phenotype of those mice. Although viable and generally healthy, Oga ⌬Br mice exhibit pleiotropic phenotypes, including a short stature, facial abnormalities, hind limb clasping, a high body fat percentage, microcephaly, enlarged ventricles, hypopituitarism, and numerous other metabolic unbalances ( Figs. 1 and 2) .
Brain O-GlcNAcase is an important regulator of metabolic homeostasis
The reduced size of the body, brain, and pituitary gland in Oga KO mice suggested that OGA must play a key regulatory role in embryonic development. The Nestin promoter driving Cre recombinase expression is transiently activated in dividing cells, mainly during early developmental stages in the central nervous system. Consequently, we anticipated that deletion of the Oga would occur early in the development of the brain and alter embryogenesis. Our observation of 17.5-dpc embryos confirms a developmental delay of around 2 days in Oga ⌬Br mice. Along with the generally reduced size of the head, the olfactory bulb, cortical neuroepithelium (forebrain), colliculus (midbrain) and metencephalon (hind brain) were significantly underdeveloped, as was the anterior pituitary gland (Fig. 2) . As noted previously, the main sites of adult neurogenesis are the olfactory epithelium and the dentate gyrus. One likely explanation for the more pronounced phenotype we observed for the olfactory bulb and dentate gyrus is that neurogenesis persists even into adulthood in these regions, thus accentuating the differences between the Oga ⌬Br mice and the wild type (29, 31) . The reduced size and reduced number of acidophils in the anterior pituitary gland observed in Oga ⌬Br mice suggests a diminished number of somatotrophs. Although the Oga ⌬Br knockout was restricted to the brain, the phenotypes we observed included early-onset obesity and dramatically increased fat production. This was associated with metabolic changes such as increased leptin, triglycerides, insulin, and adiponectin and decreased free fatty acid and insulin-like growth factor 1 (IGF-1). These findings are consistent with the hypothesis that the center of metabolic regulation in the brain, the hypothalamopituitary axis, was directly impacted by the interference with O-GlcNAcase-dependent O-GlcNAc cycling.
Brain O-GlcNAcase is a regulator of stem cell pluripotency and neurogenesis
O-GlcNAc cycling has emerged as a critical regulator of stem cell maintenance and embryonic development. Ogt is essential for ES cell viability in mice (15) , whereas both Ogt and Oga KO lead to pre-or perinatal lethality (15, 17) . During development, O-GlcNAc cycling is poised to act as a global but efficient modulator of numerous pathways, including those of the cell cycle and differentiation (38) . More importantly, the balance between proliferation and differentiation is critical for proper neuronal differentiation and brain formation. Observation of Oga ⌬Br mouse developing brain confirms an abnormal proliferation linked to the increase in O-GlcNAcylation (Fig. 4) . The adult Oga ⌬Br brain also exhibits altered cortical layering and a deficit in differentiation. Furthermore, in vitro differentiation of mESCs into neurons confirms the inability of Oga KO stem cells to differentiate into neurons on the same time scale compared with WT mESCs (Fig. 6 ). We observed that the Oga ⌬Br adult brain exhibits reduced pyramidal neurons in both the cortex and hippocampus, consistent with an altered time course of neural development (Fig. 4 ). Our analysis also suggests that the structural changes observed with loss of brain O-GlcNAcase are not associated with increases in apoptosis or disintegrative neurodegenerative damage. It will be important to extend this study to models in which neurodegeneration is triggered by known neurodegenerative insults.
The potential involvement of nutrient-driven O-GlcNAcylation in stem cell biology is an area of active investigation. OGT has been shown to physically interact with OCT4, leading to O-GlcNAcylation of this transcription factor (16) . Inhibition of the O-GlcNAcase was shown previously to delay ESC differentiation but did not affect the naïve-to-primed stem cell transition (18, 39) . Other studies have also suggested that O- GlcNAcylation may impact stem cell pluripotency (16, 40) . Many of the factors maintaining pluripotency are themselves O-GlcNAc-modified (16, 18, 41) . In this study, the inhibition of neural differentiation in Oga KO mESCs was associated with deregulation of numerous markers of stem cell pluripotency and subsequent neural differentiation. We observed a significant elevation of Sox2 transcripts and decreases in Nanog in Oga KO mESCs compared with WT mESCs. We also noted significantly elevated Nestin, Sox1, and Otx2 in Oga KO mESCs. The observed elevation in these priming/predifferentiation markers suggests a premature switch to primed pluripotency. Upon differentiation, the Oga KO mESCs maintained higher levels of transcripts encoding neural differentiation markers (Mag, Osp, Aldh1, and Gfap). Other markers, such as Map2, ChAt, and Gad1 and others, were not significantly different from WT controls. This pattern of transcriptional deregulation is intriguing given the overall inhibition of neural differentiation as measured morphologically and using neural differentiation markers (Fig. 6 ). The findings suggest that the pluripotency network in the Oga KO mESCs is significantly altered with a profound impact on developmental timing. These findings are consistent with the observed changes in developmental timing observed in Oga ⌬Br . Coupled with the findings regarding neurogenesis in Oga ⌬Br animals, these data argue that O-GlcNAc addition and removal can be exploited to alter the process of neural differentiation. 
Experimental procedures
Collection and fixation of mouse brains
The brains of 8-month-old mice were extracted following fixation by intracardiac perfusion of 4% paraformaldehyde. For neuron proliferation labeling, timed pregnant females (plug day ϭ 0.5) were injected intraperitoneally, late in pregnancy, with 20 mg/ml (in 0.9% NaCl) BrdU (Sigma) to achieve a dose of 200 mg kg Ϫ1 . The females were then euthanized 2 h later, and the embryos of post-coitus embryonic days 15.5 or 17.5 were harvested. The brains of the embryos were soaked in 4% paraformaldehyde for 3 days in the intact skull.
Histological examination
The paraformaldehyde-fixed brains were processed by Histoserv Inc. (Germantown, MD) for embedding, sectioning, H&E, BrdU, PCNA, glial fibrillary acidic protein, and DCX staining. The paraformaldehyde-fixed brains were also pro-cessed by NeuroScience Associates for embedding, sectioning, and silver staining.
Body weight, composition, and food intake
From 5 weeks after birth, body weight and food intake were measured every 1 to 2 weeks. Body composition of fat and lean mass was measured with the EchoMRI 3-in-1TM at the metabolism core facility of the NIDDK, National Institutes of Health as described previously (17) .
Hind limb extension reflex
Animals were briefly suspended by the tail in multiple trials (more than five). The position of the hind limbs was scored as follows: 0, hind limbs reflexively extend; 1, hind limbs were held at body sides; 2, hind limbs were flexed and retracted closer to the abdomen; 3, hind limbs were held to the abdomen (clasping).
Metabolite dosage
Metabolite concentrations were measured by the mouse metabolic core (NIDDK, National Institutes of Health) as described previously (17).
Cell culture
Wild-type and Oga KO mESCs were collected at embryonic days 3.5, generally following the protocol from Hogan et al. (42) . Cells were cultured in KO DMEM supplied with 15% knockout serum replacement (KSR), 1% penicillin/streptomycin, 1% L-glutamine, 1% non-essential amino acids, 0.1 mM 2-mercaptoethanol, 1000 units/ml LIF, 1 M PD0325901, and 3 M CHIR99021 (2i inhibitors). Cells were karyotyped and analyzed to confirm Oga mRNA by qPCR and protein expression by Western blotting. To induce neuronal differentiation, LIF and 2i inhibitors were replaced by all-trans retinoic acid at a final concentration of 1 M.
Immunofluorescence
Cells were cultured on two-chamber glass slides (Electron Microscopy Sciences) for 2 days. Cells were then washed twice with PBS and fixed in freshly made 4% paraformaldehyde/PBS for 15 min at room temperature. After three PBS washes (5 min each), cells were permeabilized at 4°C for 15 min in 1% Triton X-100/PBS. After three PBS washes (5 min each), slides were saturated in a 1% BSA/PBS solution for 15 min at room temperature and incubated with antibodies diluted at 1:200 in 1% BSA/ PBS for 1 h at room temperature. After three PBS washes (5 min each), cells were incubated with Alexa Fluor 488 anti-mouse IgG or 568 anti-rabbit IgG secondary antibodies (Life Technologies) diluted at 1:500 in 1% BSA/PBS for 30 min at room temperature and in the dark. Finally, cells were washed in PBS three times and mounted in DAPI/fluoromount G (Electron Microscopy Sciences). After drying, slides were observed under a confocal microscope (Zeiss LSM700).
PCR-grade water. RNA concentration was measured using a nanodrop dosage spectrophotometer, and quality was checked by running RNA on an agarose gel and analyzing the integrity of ribosomal RNA (28S and 18S). 4 l of qScript cDNA Supermix (Quanta Bioscience) was added to 500 g of RNA extract and run on a thermocycler to provide cDNA using the following program: 25°C for 5 min, 42°C for 30 min; 85°C for 5min, and 10°C/∞. Total cDNA was then quantified using a nanodrop spectrophotometer. For qRT-PCR, 1 g of cDNA was mixed with 10 l of fast SYBR Green Master Mix (Applied Biosystems) and 0.5 l of each primer (100 M) (in 20 l of PCR-grade water) and amplified on an AB 7900HT fast real-time PCR system (Applied Biosystems). Each experiment was performed in triplicate, analyzed by calculating the 2-⌬⌬CT (Livak and Schmittgen (43)) relative to actin expression, and significance was calculated with the one-way analysis of variance (GraphPad Prism v.6).
Primers
For Oga KO verification, we used Oga-F (CGGTGTCGTG-GAAGGGTTTTA) and Oga-R (GTTGCTCAGCTTCTTCC-ACTG). For endogenous control, we used Actb-F (ACCATG-GATGATGATATCGC) and Actb-R (TCATTGTAGAAGG-TGTGGTG). For stem cells, we used Sox2-F (ATGCACCG-CTACGACGTGA) and Sox2-R (CTTTTGCACCCCTCCC-ATTT), Nanog-F (CTCATCAATGCCTGCAGTTTTTCA) and Nanog-R (CTCCTCAGGGCCCTTGTCAGC), and Oct4-F (ATGGCATACTGTGGACCTC) and Oct4-R (AGCAGCT-TGGCAAACTGTTC). For neural stem cells, we used Otx2-F (GAAAATCAACTTGCCAGAATCCA) and Otx2-R (GCG-GCACTTAGCTCTTCGAT), Sox1-F (GCGGAAAGCGTTT-TCTTG) and Sox1-R (TAATCTGACTTCTCCTCCC), and Nestin-F (CAGCGTTGGAACAGAGGTTGG) and Nestin-R (TGGCACAGGTGTCTCAAGGGTAG). For oligodendrocytes, we used Mag-F (TCTGGATTATGATTTCAGCC) and Mag-R (GCTCTGAGAAGGTGTACTGG) and Osp-F (ACT-GCTGCTGACTGTTCTTC) and Osp-R (GTAGAAACGGT-TTTCACCAA). For astrocytes, we used Aldh1L1-F (TCAC-AGAAGTCTAACCTGCC) and Aldh1L1-R (AGTGACGGG-TGATAGATGAT) and Gfap-F (GTACCAGGACCTGCT-CAAT) and Gfap-R (CAACTATCCTGCTTCTGCTC). For neurons, we used Map2-F (CCACCTGAGATTAAGGATCA) and Map2-R (GGCTTACTTTGCTTCTCTGA) and Chat-F (ACTGGGTGTCTGAGTACTGG) and Chat-R (TTGGAAG-CCATTTTGACTAT). For GABAergic/glutaminergic neurons, we used Gad1-F (GTCGAGGACTCTGGACAGTA) and Gad1-R (GGAAGCAGATCTCTAGCAAA). For serotonergic neurons, we used Slc6A4-F (GCCTTTTACATTGCTTCCTA) and Slc6A4-R (CCAATTGGGTTTCAAGTAGA). For cho linergic neurons, we used Chat-F (ACTGGGTGTCTGAGTA-CTGG) and Chat-R (TTGGAAGCCATTTTGACTAT). For dopaminergic neurons, we used Th-F (TCATCACCTGGT-CACCAAGTT) and Th-R (GGTCGCCGTGCCTGTACT).
SDS-PAGE and Western blotting
Protein was extracted with Tissue Protein Extraction Reagent (T-PER) tissue protein extraction reagent (Thermo Scientific) or Xtractor buffer (Clontech). Protein lysate was centrifuged at 14,000 rpm for 10 min. After discarding the pellet, Laemmli 5ϫ was added to the lysate and boiled at 100°C for 10 min. Protein lysate was then run in 4 -20% SDS-PAGE gel, and the transferred nitrocellulose membrane was blotted with primary antibodies.
Antibodies
Anti-O-GlcNAc antibody (RL2, Abcam) was used at 1:1000 dilution. Anti-␤-tubulin (Abcam) and anti-actin (Abcam) were used at 1:5000 dilution. Anti-OGA (Sigma) and anti-Ogt (DM17, Sigma) were used at 1:2000 dilution. Streptavidin-conjugated antibody was used at 1:5000 dilution. Anti-␤3-tubulin (Cell Signaling Technology) was used at a concentration of 1:500 dilution for immunofluorescence only.
